Agora Financial Features ISCO in latest edition of Breakthough Technology Alert newletter

Breakthrough Technology Alert writer Ray Blanco features ISCO in his latest newsletter.  I've copied a little of the text below (with the permission of the author)

--------------------------------------------------------------------------------------------
September 4, 2013

Important News: Stem Cell Specialists Moving Into Clinical Trials

Dear Breakthrough Technology Alert Reader,


ISCO Enters Into Clinical Agreement 

International Stem Cell Corp. (OTCBB: ISCO) is going to be entering clinical trials soon. The company is developing its unique, ethical human parthenogenetic neural stem cell (hPNSC) technology into a treatment for Parkinson's disease................



You'll have to login here to read the whole post breakthroughtechnologyalert.agorafinancial.com